Finally, long-standing diabetes patients require an exogenous insulin injection to sustain high-insulin concentration, which is the so-called “exogenous hyperinsulinemia.” Moreover, a unique portal structure enables insulin secreted from the pancreatic islet to perfuse the exocrine pancreas first, significantly increasing the regional insulin concentration in PDA tissue. The gene discussed is INS; the disease is Hyperinsulinemia.